Cory Renauer
Value, research analyst, biotech, small-cap

Cytori Therapeutics Using Your Fat To Heal Your Heart

Cytori Therapeutics (NASDAQ:CYTX) is a not yet profitable marketer of tissue regeneration therapies based in San Diego. Cytori's proprietary platform employs adipose-derived stem and regenerative cells (ADRCs). The company receives regular revenues from sales of its Puregraft, and other systems to researchers and healthcare providers around the world. Cytori's product, and research grant revenue streams partially fund its investments into clinical development of its cell therapies for cardiovascular and burn therapies.

Pumped up for cardiovascular therapies

Cytori's future hangs heavily on the development of its cardiovascular disease therapeutic pipeline. Myocardial ischemia is a disease characterized by insufficient blood supply to heart muscle caused by a rupture along the coronary artery. Cytori, of course, would like to market its...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details